| 5942 |
Centers for Disease Control and Prevention |
Html |
en |
o-sec-Butylphenol - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6106 |
Centers for Disease Control and Prevention |
Html |
en |
4-Methoxyphenol - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7057 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Guinea-Bissau |
null |
| Content source | 0.892652 |
| HHS | 0.699811 |
| endorsement | 0.682673 |
| CDC | 0.617915 |
|
| non-federal site | 0.998525 |
| Notice | 0.617482 |
| sponsors | 0.49087 |
| information | 0.490002 |
|
CLICK HERE |
| 7663 |
Centers for Disease Control and Prevention |
Html |
en |
Off the Beaten Path: Violence, Women, and Art |
David J. Sencer CDC Museum |
| storytelling | 0.445367 |
| better understanding | 0.636715 |
| project | 0.475839 |
| girls | 0.476495 |
| hope | 0.43815 |
| issues | 0.477657 |
| executive director | 0.648156 |
| cutting-edge art | 0.672441 |
| themes | 0.437328 |
| basic human rights | 0.879973 |
| Yoko Ono | 0.720253 |
| awareness | 0.475565 |
| action | 0.44052 |
| nonprofit group Art | 0.856013 |
| Culture | 0.436962 |
| Beaten Path | 0.994825 |
| Randy Jayne Rosenberg | 0.895216 |
| important social messaging | 0.862091 |
| goal | 0.43886 |
| Japan | 0.442771 |
| important topic | 0.633104 |
| feeling | 0.451033 |
| countries | 0.442893 |
| Individual | 0.437232 |
| various definitions | 0.630715 |
|
| actions | 0.437668 |
| Hank Willis Thomas | 0.907078 |
| Wangechi Mutu | 0.665496 |
| women | 0.476572 |
| abuse | 0.437851 |
| contemporary artists | 0.667916 |
| inspiration | 0.442344 |
| world | 0.441913 |
| new conversation | 0.645776 |
| Art Works | 0.845575 |
| audiences | 0.44218 |
| France | 0.442628 |
| violence | 0.797955 |
| exhibition | 0.43803 |
| USA | 0.44224 |
| address systems | 0.653492 |
| positive social change | 0.862909 |
| Kenya | 0.448942 |
| beliefs | 0.437531 |
| secure life | 0.660021 |
| Palestine | 0.455024 |
| Family | 0.437136 |
| Mona Hatoum | 0.68242 |
| Community | 0.437039 |
|
CLICK HERE |
| 9110 |
Centers for Disease Control and Prevention |
Html |
en |
Exchange Transfusion - Malaria |
Malaria is a mosquito-borne disease caused by a parasite. CDC provides scientific leadership in fighting malaria at home and around the globe. |
| severe malaria | 0.953733 |
| CDC | 0.369135 |
| fact | 0.315352 |
| intravenous quinidine | 0.388233 |
| evidence | 0.349888 |
| data | 0.314688 |
| United States | 0.384968 |
| portion | 0.3169 |
| antimalarials | 0.315514 |
| significant association | 0.377859 |
| respiratory distress syndrome | 0.595819 |
| renal compromise | 0.388435 |
| survival outcome | 0.382603 |
| antimalarial drugs | 0.400915 |
| Adverse events | 0.378162 |
| exchange transfusion | 0.481979 |
| infected cells | 0.390146 |
| comprehensive study | 0.378625 |
| published literature | 0.376539 |
|
| adjunct ET | 0.509269 |
| cerebral malaria | 0.465888 |
| adjunct treatment | 0.406439 |
| toxic byproducts | 0.392081 |
| hypotension | 0.319437 |
| ventricular fibrillation | 0.384234 |
| acute respiratory distress | 0.600148 |
| complications | 0.315577 |
| entirety | 0.319241 |
| high parasite loads | 0.454134 |
| patients | 0.330635 |
| countries | 0.315553 |
| procedure | 0.315485 |
| National Malaria Surveillance | 0.524225 |
| rationale | 0.318754 |
| efficacy | 0.317835 |
| ET | 0.787431 |
| infected patient | 0.392683 |
|
CLICK HERE |
| 11515 |
Centers for Disease Control and Prevention |
Html |
en |
NCIRD | Websites Managed |
null |
| National Center | 0.657499 |
| Immunization | 0.423732 |
| DBD | 0.436367 |
| Viral Diseases | 0.676975 |
| Page | 0.400519 |
| Bacterial Diseases | 0.683074 |
| divisions | 0.377586 |
|
| content | 0.348533 |
| following web sites | 0.916961 |
| DVD | 0.352558 |
| CDC web teams | 0.850403 |
| Respiratory Diseases | 0.667592 |
| topic | 0.373088 |
|
CLICK HERE |
| 12378 |
Centers for Disease Control and Prevention |
Image |
null |
Breast Cancer: Know the Risks (600W x 2182H) |
null |
|
|
CLICK HERE |
| 12482 |
Centers for Disease Control and Prevention |
Video |
en |
October 2013 ACIP Meeting -- Vaccine Supply |
Vaccine supply update by Dr. J Santoli
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at
http://streaming.cdc.gov/vod.php?id=60aaea444bbc2b7e07f4cabd5832b56920140110114625308 |
|
|
CLICK HERE |
| 13429 |
Centers for Disease Control and Prevention |
Html |
en |
Use of Aspirin for Prevention of Recurrent AtheroscleroticCardiovascular Disease Among Adults - 20 States and the District ofColumbia, 2013 |
Jing Fang, MD1; Mary G. George, MD1; Yuling Hong, MD, PhD1; Fleetwood Loustalot, PhD1 (Author affiliations at end of text). |
| annual telephone survey | 0.573014 |
| fatal coronary events | 0.587123 |
| myocardial infarction | 0.584564 |
| National Health Interview | 0.577235 |
| Associated Risk Factors | 0.57189 |
| Public health practitioners | 0.573907 |
| optional BRFSS modules | 0.575419 |
| cardiovascular disease event | 0.585497 |
| data collection methods | 0.585132 |
| health care providers | 0.575125 |
| secondary prevention | 0.582521 |
| health care services | 0.575267 |
| ASCVD risk factors | 0.688772 |
| hemorrhagic stroke accounts | 0.59184 |
| BRFSS cardiovascular health | 0.593758 |
| ischemic vascular disease | 0.596618 |
| sociodemographic characteristics | 0.587699 |
| different risk groups | 0.574014 |
| regular aspirin therapy | 0.798941 |
| Behavioral Risk Factor | 0.581202 |
| current guidelines | 0.573845 |
| heart attack | 0.813753 |
| median state response | 0.574291 |
| ASCVD risk status | 0.604103 |
|
| atherosclerotic cardiovascular disease | 0.659529 |
| eligible respondents | 0.604806 |
| State Public Health | 0.583994 |
| secondary ASCVD prevention | 0.706398 |
| states | 0.607439 |
| acute coronary syndrome | 0.585298 |
| ASCVD risk factor | 0.595999 |
| heart attack prevention | 0.656305 |
| risk factors management | 0.572083 |
| cardiovascular health module | 0.707928 |
| pain relief | 0.615364 |
| ischemic stroke | 0.603925 |
| cardiovascular disease | 0.705769 |
| Million Hearts initiative | 0.609187 |
| antiplatelet medications | 0.592662 |
| Promote School Health | 0.577212 |
| regular aspirin | 0.980409 |
| stroke | 0.668975 |
| Chronic Disease Prevention | 0.624592 |
| Mary G. George | 0.577922 |
| cardiovascular disease events | 0.5898 |
| coronary heart disease | 0.731429 |
| stroke prevention | 0.657322 |
| cardiovascular disease prevention | 0.609005 |
|
CLICK HERE |
| 14282 |
Centers for Disease Control and Prevention |
Html |
en |
Opioid Overdose State Data |
null |
| drug overdose deaths | 0.651659 |
| North Carolina | 0.200873 |
| Rhode Island | 0.400119 |
| New York | 0.208425 |
| drug overdose death | 0.825415 |
| Multiple Cause Mortality | 0.356814 |
| statistically significant increases | 0.428164 |
| main driver | 0.232302 |
| significant increases | 0.438163 |
| drug overdose | 0.971761 |
| National Vital Statistics | 0.351366 |
| highest rates | 0.215317 |
|
| Wide-ranging Online Data | 0.359936 |
| New Jersey | 0.208693 |
| West Virginia | 0.397181 |
| overdose death rates | 0.828677 |
| South Census Regions | 0.375626 |
| opioid overdoses | 0.262924 |
| New Hampshire | 0.386334 |
| nonfatal injury | 0.215231 |
| public health professionals | 0.348666 |
| Epidemiologic Research | 0.208003 |
| public health information | 0.341414 |
|
CLICK HERE |